Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-576,726
Closed -$2.83M 355
2015
Q3
$2.83M Sell
576,726
-79,253
-12% -$430K 0.58% 51
2015
Q2
$4M Sell
655,979
-4,633
-0.7% -$28.6K 0.73% 41
2015
Q1
$3.81M Buy
660,612
+74,816
+13% +$464K 0.7% 47
2014
Q4
$3.64M Sell
585,796
-101,889
-15% -$644K 0.69% 47
2014
Q3
$4.5M Buy
687,685
+8,753
+1% +$61.6K 0.88% 36
2014
Q2
$4.78M Buy
+678,932
New +$5M 0.88% 36

Other funds holding ABEV

Stanley-Laman Group's ABEV Position: Q4 2015 in Review

Stanley-Laman Group sold out of Ambev (ABEV) in Q4 2015, closing a stake of 576,726 shares — an estimated $2.83M sold.

Stanley-Laman Group first reported a position in ABEV in Q2 2014 and held it in 6 quarters. The position peaked at $4.78M in Q2 2014. 302 funds tracked by Wall St. Rank hold ABEV as of Q4 2015.

  • Stanley-Laman Group reported no remaining Ambev position as of Q4 2015 after selling out during the quarter.
  • Stanley-Laman Group sold 576,726 Ambev shares in Q4 2015, an estimated $2.83M.
  • Stanley-Laman Group first reported a position in Ambev in Q2 2014 and held it in 6 quarters.
  • Stanley-Laman Group's Ambev position peaked at $4.78M in Q2 2014.
  • 302 funds tracked by Wall St. Rank held Ambev as of Q4 2015.

Based on Stanley-Laman Group's 13F filing for Q4 2015, filed 26 Jan 2016.